Caris rises on $1.1 billion deal with Genentech

Caris Life Sciences

16/12/2025 17:58

** Shares of AI-driven oncology firm Caris Life Sciences CAI.O up 2.23% at $27.30

** Co has signed a multi-year collaboration with Genentech, to discover new drug targets for hard-to-treat cancers

** Deal includes $25 mln upfront and near-term payments, with milestones of up to $1.1 bln linked to R&D and sales, Caris says

** Including session's moves, shares up ~2.40% YTD

 (Reporting by Megha Kumari)

 ((Megha.Kumari@thomsonreuters.com;))